HIND · Vyome Holdings Inc
United States · RS rating 19 · As of 2026-10-14
| Price | 1.93 USD |
|---|---|
| 1-day change | -2.0% |
| RS rating (overall / 1M / 3M / 12M) | 19 / 41 / 29 / 11 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 5 / 33 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +33.3% |
| Sales growth Q/Q | +5.6% |
| Distance from 52-week high | +69.4% |
| Market cap (USD) | $15.9M |